Handelsavisen
prelaunch
Companies Basic Materials ASH.AX
AS
ASH.AX ASX Diversified Chemicals

Ash.Ax

A$0,26
Open in Charts → Attach watcher ⌖
AUD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
37,9M AUD
P/E
EV / Rev
Div yield
10,53 %
Op margin
1,0 %
ROE
7,0 %
Net margin
0,4 %
Debt / equity
0,46
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
2026-11-09
Ex-dividend
TR 1Y
About

ASH.AX operates in the Employment Services industry, providing staffing and recruitment services to clients across various sectors.

Business. ASH.AX operates in the Employment Services industry, providing staffing and recruitment services to clients across various sectors.

Classification99 %
SectorBasic Materials
Industry groupDiversified Chemicals
Generated · model-assisted
Sell-side consensus
BUY12 analysts
9 buy3 hold0 sell
Avg 12m price target68,85

Analyst recommendations

12 analysts · consensus Buy
Buy9
Hold3
Sell0
12-month price target
68,85
Consensus of sell-side coverage.
Upcoming events
  • EarningsFY 2026 earnings (expected)2026-11-09 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
Buy
12 analysts · indicative
Ownership
not yet wired
Profitability
7,0 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning ASH.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials · THIS SECTOR+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to ASH.AX. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsFY 2026 earnings (expected)2026-11-09 · estimated
    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    Briefing · model-assisted

    Ashland Inc (ASH.O) has undergone a significant update to its risk assessment profile, with dilution risk now explicitly classified as "low" and liquidity risk designated as "medium." These new field assignments provide a clearer baseline for evaluating the company's capital structure stability and cash flow management capabilities, replacing previous undefined states with actionable risk metrics. Concurrently, the company's taxonomy classification for both activity and economic sector has been updated to "Unclassified." This change, marked with medium severity, indicates a gap in specific sectoral categorization that may require further clarification for investors relying on standardized industry benchmarks for comparative analysis. The AI analysis narrative has also been revised, reflecting an updated thesis on the company's operational and financial outlook. This modification suggests a shift in the qualitative assessment of Ashland's strategic positioning, though specific details of the narrative change are not elaborated in the current data set. With 32 top holders identified and no current analyst or index membership counts reported, the updated risk and classification data serves as a foundational layer for stakeholder evaluation. The combination of low dilution risk and medium liquidity risk offers a nuanced view of Ashland's financial health, while the unclassified taxonomy highlights areas where further data granularity may be needed for comprehensive investment decision-making.

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    ASH.AX operates in the Employment Services industry, providing staffing and recruitment services to clients across various sectors.

    Classification99 %
    SectorBasic Materials
    Industry groupDiversified Chemicals
    AI synthesis
    GENERATED

    ASH.AX has a market capitalization of $31.94 million and a price-to-earnings ratio of 14.71, indicating a moderate valuation relative to its earnings. The company's price-to-book ratio of 1.03 suggests that the market value is closely aligned with its book value. The enterprise value to EBITDA ratio of 8.76 indicates that the company is valued at a relatively low multiple of its earnings before interest, taxes, depreciation, and amortization. The company's liquidity position is characterized as medium, with a current ratio of 1.06, suggesting that it has a slight buffer to cover its short-term liabilities.

    In terms of profitability, ASH.AX has a return on equity of 6.98% and a return on assets of 2.51%, which are below the industry median for Employment Services. The company's operating income of $5.3 million and net income of $2.17 million indicate a modest profit margin. The debt-to-equity ratio of 0.46 suggests that the company is not heavily leveraged, which is a positive sign for financial stability.

    ASH.AX's revenue is concentrated in a single business segment, with no disclosed geographic diversification. The company's revenue of $515.94 million is derived from staffing and recruitment services, with no significant diversification into other product lines or markets. The lack of geographic diversification may expose the company to regional economic fluctuations.

    The company's growth trajectory is expected to remain stable, with no significant changes in revenue or earnings projected for the next fiscal year. The capital expenditure of -$877,000 indicates that the company is generating more cash from operations than it is investing in new assets. The free cash flow of $3.56 million suggests that the company has sufficient liquidity to fund operations and potentially return value to shareholders.

    The risk assessment for ASH.AX indicates a medium liquidity risk and a low dilution risk. The company's net cash position is negative after subtracting total debt, which could impact its ability to fund operations without external financing. The dilution risk is low, with no significant dilution expected in the near term. The company's financial structure and performance suggest that it is not currently facing significant financial distress.

    Recent events and filings for ASH.AX have not indicated any material changes in the company's operations or financial position. The company's financial statements and disclosures have not revealed any significant risks or liabilities that would impact its future performance.

    Ashland Inc (ASH.O) has undergone a significant update to its risk assessment profile, with dilution risk now explicitly classified as "low" and liquidity risk designated as "medium." These new field assignments provide a clearer baseline for evaluating the company's capital structure stability and cash flow management capabilities, replacing previous undefined states with actionable risk metrics. Concurrently, the company's taxonomy classification for both activity and economic sector has been updated to "Unclassified." This change, marked with medium severity, indicates a gap in specific sectoral categorization that may require further clarification for investors relying on standardized industry benchmarks for comparative analysis. The AI analysis narrative has also been revised, reflecting an updated thesis on the company's operational and financial outlook. This modification suggests a shift in the qualitative assessment of Ashland's strategic positioning, though specific details of the narrative change are not elaborated in the current data set. With 32 top holders identified and no current analyst or index membership counts reported, the updated risk and classification data serves as a foundational layer for stakeholder evaluation. The combination of low dilution risk and medium liquidity risk offers a nuanced view of Ashland's financial health, while the unclassified taxonomy highlights areas where further data granularity may be needed for comprehensive investment decision-making.

    Key takeaways
    • ASH.AX is moderately valued with a price-to-earnings ratio of 14.71 and a price-to-book ratio of 1.03.
    • The company's return on equity of 6.98% is below the industry median for Employment Services.
    • ASH.AX's revenue is concentrated in a single business segment with no geographic diversification.
    • The company's liquidity position is characterized as medium, with a current ratio of 1.06.
    • ASH.AX has a low dilution risk and a negative net cash position after subtracting total debt.

    Bull / Bear case

    Generated · model-assisted
    — missing data

    In focus — financials by report

    Valuation

    Market price
    A$0,26
    Market cap
    A$31.9M
    Enterprise value
    A$46.4M
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    5.2x
    P / B
    1.0x
    P / Tangible book
    1.0x
    Tangible book
    A$31.1M
    Net cash
    -A$14.5M
    Current ratio
    1.1
    Debt / equity
    0.5
    ROA
    2.5%
    ROE
    7.0%
    Cash conversion
    408.0%
    CapEx / revenue
    -0.2%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    INDUSTRYSEGMENTCOMPANYBasic MaterialsIndustryDiversified Chemicals41,4B node revenueSSL 36,9%GRN 31,0%CC 14,0%HUN 13,7%ASH 4,4%AGIG 0,0%
    Source: company disclosures · own-taxonomy revenue-covered set · attribution: collision-suspect (indicative)ASH 4,4% · rank #5 of 6

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    Peer comparison5 peers · vs ASH · multiples and returns
    SS
    SSL
    Sasol Ltd
    P/E
    vs self
    Div yield
    vs self
    ROE
    vs self
    GR
    GRN
    GRN.MI
    P/E
    vs self
    Div yield
    vs self
    ROE
    vs self
    CC
    CC
    Chemours Co
    $17,11
    2,6B USD
    P/E
    vs self
    Div yield
    1,9 %
    -0,5 vs self
    ROE
    -179,5 %
    vs self
    HU
    HUN
    Huntsman Corp
    $11,43
    2,0B USD
    P/E
    vs self
    Div yield
    7,3 %
    +4,9 vs self
    ROE
    -10,6 %
    vs self
    AG
    AGIG
    Abundia Global Impact Group
    $0,95
    38,2M USD
    P/E
    vs self
    Div yield
    vs self
    ROE
    -83,3 %
    vs self

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 49 %
    EPS
    Consensus EPS
    3,60
    Predicted surprise
    +0,01
    Beat probability
    49 %
    Analysts
    12
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-06-25 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    LowA$50,00
    MeanA$68,85
    MedianA$68,00
    HighA$90,00
    SpotA$0,26
    +26898.2 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin1,0 %Below median
    Net Margin0,4 %Below median
    ROE7,0 %Above median
    Capex / Rev-0,2 %Above P75
    D/E0,46Below median
    Cash Conv4,08Above P75

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    Derivative transactions

    Net acquired 308 687 sh5 exercises · 33 grants17 insiders
    • MUSA OSAMA MSVP and CTO · Stock Appreciation Rights → Common StockDisposed 9 793 @ $57,96exercise · 2026-07-29
    • Assis Alessandra FaccinSVP and GM, Life Sciences · Restricted Stock Unit → Common StockDisposed 3 215exercise · 2026-07-27
    • Bishop Steven DDirector · Common Stock Units → Common StockAcquired 379grant · 2026-06-30
    • Chattopadhyay SanatDirector · Common Stock Units → Common StockAcquired 218grant · 2026-06-30
    • LOY BERTRANDDirector · Restricted Stock Units → Common StockAcquired 1 741grant · 2026-05-15
    • MINICUCCI JAMES P.SVP and GM, Personal Care · Restricted Stock Unit → Common StockDisposed 4 310exercise · 2026-05-08
    • Bishop Steven DDirector · Common Stock Units → Common StockAcquired 450grant · 2026-03-31
    • Chattopadhyay SanatDirector · Common Stock Units → Common StockAcquired 258grant · 2026-03-31
    • NOVO GUILLERMODirector, Chair of the Board and CEO · Restricted Stock Units → Common StockAcquired 32 096grant · 2026-02-06
    • Kulkarni Ashish KDirector · Restricted Stock Units → Common StockAcquired 2 113exercise · 2026-01-21
    • Peribere Jerome ADirector · Restricted Stock Units → Common StockAcquired 2 449grant · 2026-01-20
    • Chattopadhyay SanatDirector · Restricted Stock Units → Common StockAcquired 2 449grant · 2026-01-20
    • Bishop Steven DDirector · Restricted Stock Units → Common StockAcquired 2 449grant · 2026-01-20
    • Kulkarni Ashish KDirector · Restricted Stock Units → Common StockAcquired 2 449grant · 2026-01-20
    • Harrison Suzan F.Director · Restricted Stock Units → Common StockAcquired 2 449grant · 2026-01-20
    • Tozier ScottDirector · Restricted Stock Units → Common StockAcquired 2 449grant · 2026-01-20
    • MAIN SUEDirector · Restricted Stock Units → Common StockAcquired 2 449grant · 2026-01-20
    • Bishop Steven DDirector · Common Stock Units → Common StockAcquired 426grant · 2025-12-31
    • Chattopadhyay SanatDirector · Common Stock Units → Common StockAcquired 245grant · 2025-12-31
    • Caceres DagoSVP & GM, Specialty Additives · Restricted Stock Units → Common StockAcquired 4 250grant · 2025-11-19
    • Assis Alessandra FaccinSVP and GM, Life Sciences · Restricted Stock Units → Common StockAcquired 6 136grant · 2025-11-19
    • Assis Alessandra FaccinSVP and GM, Life Sciences · Stock Appreciation Rights → Common StockAcquired 13 807 @ $50,58grant · 2025-11-19
    • LAMPKIN ROBIN E.SVP, Gen Counsel and Secrty. · Restricted Stock Units → Common StockAcquired 3 965grant · 2025-11-19
    • LAMPKIN ROBIN E.SVP, Gen Counsel and Secrty. · Stock Appreciation Rights → Common StockAcquired 8 922 @ $50,58grant · 2025-11-19
    • NOVO GUILLERMODirector, Chair of the Board and CEO · Restricted Stock Units → Common StockAcquired 43 495grant · 2025-11-19

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Ev To Operating Cash Flow
      enterprise_value / operating_cash_flow
    • Return On Equity
      net_income / total_equity
    • Price To Earnings
      market_price / (net_income / shares_outstanding_diluted)
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    Source documents
    • ASH.AX Market data — financials · 2026-05-27

    Ownership & reference

    Insider activity

    Mixed / flat0 buys · 0 sellsnet $05 insiders · last 365d
    • MUSA OSAMA MSVP and CTO · Common StockOther 1 267 @ $57,96$73K · 2026-07-29
    • Assis Alessandra FaccinSVP and GM, Life Sciences · Common StockOther 884 @ $66,38$59K · 2026-07-27
    • Assis Alessandra FaccinSVP and GM, Life Sciences · Common StockOther 3 215 @ $66,38$213K · 2026-07-27
    • MINICUCCI JAMES P.SVP and GM, Personal Care · Common StockOther 1 346 @ $55,01$74K · 2026-05-08
    • MINICUCCI JAMES P.SVP and GM, Personal Care · Common StockOther 4 310 @ $55,01$237K · 2026-05-08
    • Kulkarni Ashish KDirector · Common StockOther 2 113 · 2026-01-21
    • NOVO GUILLERMODirector, Chair of the Board and CEO · Common StockOther 6 122 @ $49,60$304K · 2025-11-17
    • NOVO GUILLERMODirector, Chair of the Board and CEO · Common StockOther 2 563 @ $49,60$127K · 2025-11-17

    Short positioning

    5.7Mshares short-0.7% vs prior
    9.72days to cover
    52.6%short of daily vol
    1.1Kfails-to-deliver
    as of 2026-07-15 · short-interest report (free)

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    ASH.AXCanonical
    ASX · AUD

    Intel & risk

    PredictorBeat prob49 %Surprise+0,01Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.

    Evidence & claims

    From filings & derived data
    • Shareholders' equity (YoY) (2025-12-31 vs 2024-12-31): -27.5%Derived (calculated)
    • Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 38.8%Derived (calculated)
    • Current ratio (FY 2025-12-31): 3.15xDerived (calculated)
    • Total assets (YoY) (2025-12-31 vs 2024-12-31): -13.6%Derived (calculated)
    • Long-term debt (YoY) (2025-12-31 vs 2024-12-31): 5.6%Derived (calculated)
    • Total assets (annual): USD 4.52BSEC XBRL filing
    • Shareholders' equity (annual): USD 1.88BSEC XBRL filing
    • Current assets (annual): USD 1.15BSEC XBRL filing
    • Current liabilities (annual): USD 366MSEC XBRL filing
    • Long-term debt (annual): USD 1.39BSEC XBRL filing
    • Cash & equivalents (annual): USD 304MSEC XBRL filing
    • Gross profit (YoY) (2025-09-30 vs 2024-09-30): -11.2%Derived (calculated)
    • Gross margin (FY 2025-09-30): 30.1%Derived (calculated)
    • Capex (YoY) (2025-09-30 vs 2024-09-30): -28.5%Derived (calculated)
    • Cost of revenue (YoY) (2025-09-30 vs 2024-09-30): -14.7%Derived (calculated)
    • EPS (basic) (YoY) (2025-09-30 vs 2024-09-30): -636.2%Derived (calculated)
    • EPS (diluted) (YoY) (2025-09-30 vs 2024-09-30): -642.6%Derived (calculated)
    • Operating income (YoY) (2025-09-30 vs 2024-09-30): -2,880.8%Derived (calculated)
    • R&D expense (YoY) (2025-09-30 vs 2024-09-30): -1.8%Derived (calculated)
    • Revenue (YoY) (2025-09-30 vs 2024-09-30): -13.7%Derived (calculated)
    • EPS (diluted) (annual): USD-PER-SHARES -18SEC XBRL filing
    • Cost of revenue (annual): USD 1.27BSEC XBRL filing
    • Pre-tax income (annual): USD -809MSEC XBRL filing
    • R&D expense (annual): USD 54MSEC XBRL filing
    Showing 24 of 60 surfaced claims.
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-11-09EVENTUpcomingFY 2026 earnings (expected) estimated date
    2026-08-01 04:29 UTCFILINGMaterial 8-K
    2026-07-29 07:42 UTCEVENTEarnings Window
    2026-07-29EVENTQ3 2026 earnings (expected) estimated date
    2026-07-29INSIDERMUSA OSAMA M transacted 1.3k sh — SVP and CTO ~$73k
    2026-07-29INSIDERMUSA OSAMA M disposed of 9.8k sh Stock Appreciation Rights — SVP and CTO
    2026-07-28 00:00 UTCTRANSCRIPTEarnings call — Q3 2026
    2026-07-28EVENTQ2 2026 earnings (expected) estimated date
    2026-07-27INSIDERAssis Alessandra Faccin transacted 3.2k sh — SVP and GM, Life Sciences ~$213k
    2026-07-27INSIDERAssis Alessandra Faccin transacted 884 sh — SVP and GM, Life Sciences ~$59k
    2026-07-27INSIDERAssis Alessandra Faccin disposed of 3.2k sh Restricted Stock Unit — SVP and GM, Life Sciences
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-06-30INSIDERBishop Steven D acquired 379 sh Common Stock Units — Director
    2026-06-30INSIDERChattopadhyay Sanat acquired 218 sh Common Stock Units — Director
    2026-06-20 12:34 UTCANALYSTAnalyst coverage initiated
    2026-05-29FILING8-K filing →
    2026-05-18FILING8-K filing →
    2026-05-15 00:00 UTCINSIDER4 insider transactions — 2026-05 · net buy $163k 2 derivative
    2026-05-15INSIDERLOY BERTRAND acquired 1.7k sh Restricted Stock Units — Director
    2026-05-08INSIDERMINICUCCI JAMES P. transacted 1.3k sh — SVP and GM, Personal Care ~$74k
    2026-05-08INSIDERMINICUCCI JAMES P. transacted 4.3k sh — SVP and GM, Personal Care ~$237k
    2026-05-08INSIDERMINICUCCI JAMES P. disposed of 4.3k sh Restricted Stock Unit — SVP and GM, Personal Care
    2026-05-01 15:58 UTCFILINGRegulatory filing →
    2026-04-29FILING10-Q filing →
    2026-04-28FILING8-K filing →
    2026-03-31 00:00 UTCINSIDER2 insider transactions — 2026-03 2 derivative
    2026-03-31INSIDERChattopadhyay Sanat acquired 258 sh Common Stock Units — Director
    2026-03-31INSIDERBishop Steven D acquired 450 sh Common Stock Units — Director
    2026-02-06 00:00 UTCINSIDER1 insider transaction — 2026-02 1 derivative
    2026-02-06INSIDERNOVO GUILLERMO acquired 32.1k sh Restricted Stock Units — Director, Chair of the Board and CEO
    2026-02-03FILING10-Q filing →
    2026-02-02FILING8-K filing →
    2026-01-27FILING8-K filing →
    2026-01-22FILING8-K filing →
    2026-01-21 00:00 UTCINSIDER9 insider transactions — 2026-01 8 derivative
    2026-01-21INSIDERKulkarni Ashish K transacted 2.1k sh — Director
    2026-01-21INSIDERKulkarni Ashish K acquired 2.1k sh Restricted Stock Units — Director
    2026-01-20INSIDERBishop Steven D acquired 2.4k sh Restricted Stock Units — Director
    2026-01-20INSIDERKulkarni Ashish K acquired 2.4k sh Restricted Stock Units — Director
    2026-01-20INSIDERMAIN SUE acquired 2.4k sh Restricted Stock Units — Director
    Showing the 40 most recent of 60 entries.
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage